BeBetter Med Inc. (SHSE: 688759)
Health Care · Biotechnology · CN
CN¥21.69
-3.47% today · -30.1% 1Y
BeBetter Med Inc. (SHSE: 688759) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.46B.
Over the last twelve months the share price has lost 30.1%, trading between 19.98 and 57.47.
Tweenvest scores BeBetter Med Inc. across four factors: quality 42/100, value 74/100. Its strongest factor is value.
688759 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.46B
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.41
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- CN¥57.47
- 52-week low
- CN¥19.98
- Avg volume (3M)
- —
- Shares outstanding
- 450.04M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc.NasdaqGS: RARE | $1.50B | $15.29 | +0.46% |
| Biotest GmbH & Co. KGaAHMSE: BIO0 | $1.48B | €33.20 | -0.60% |
| D&D Pharmatech Inc.KOSDAQ: A347850 | $1.46B | ₩43,000.00 | -3.37% |
| Staidson (Beijing) BioPharmaceuticals Co., Ltd.SZSE: 300204 | $1.46B | CN¥20.44 | +2.10% |
| Bonesupport Holding AB (publ)OM: BONEX | $1.45B | Skr230.20 | +3.41% |
| Idorsia LtdSWX: IDIA | $1.45B | CHF4.46 | +0.45% |
| Hugel, Inc.KOSDAQ: A145020 | $1.44B | ₩180,100.00 | -3.69% |
| Taysha Gene Therapies, Inc.NasdaqGS: TSHA | $1.44B | $4.43 | 0.00% |
Figures last refreshed Oct 4, 2026.